Ligence Heart vs Tempus ECG-AF
AI Verdict
Choose Ligence Heart if…
Choose Ligence Heart if your cardiology department aims to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis and reporting. This platform is ideal for automating comprehensive cardiac assessments, including view classification, measurements, and generating detailed reports for various heart conditions.
View Ligence Heart →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your healthcare facility prioritizes proactive risk stratification for new-onset atrial fibrillation in older adult populations. This AI-based algorithm is specifically designed to analyze 12-lead ECGs from patients aged 65 or older to identify those at increased risk of developing AF within the next 12 months, facilitating earlier intervention.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Ligence Heart | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact-for-pricing | Contact vendor |
| Deployment | Cloud-based; on-premise; hybrid | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Ligence HeartLigence Heart is a web-based platform with an intuitive user interface designed for direct interaction by cardiologists and sonographers, automating complex tasks and report generation to streamline workflows. In contrast, Tempus ECG-AF is an algorithm designed without a dedicated user interface, integrating into existing systems as a backend process, offering no direct user experience.
Clinical Value
Tempus ECG-AFTempus ECG-AF provides a novel predictive risk assessment, identifying patients at increased risk of developing atrial fibrillation within 12 months, enabling proactive intervention and potentially preventing serious events like stroke. While Ligence Heart enhances the efficiency and accuracy of existing echocardiography diagnostic workflows for multiple conditions, Tempus ECG-AF's focus on future risk prediction offers a distinct and impactful clinical advantage.
Pricing & Value
Tempus ECG-AFTempus ECG-AF explicitly details CMS reimbursement availability with specific CPT codes and a Medicare rate, providing a clear financial pathway and established value for healthcare providers. Ligence Heart's pricing is less transparent, requiring direct contact for an enterprise quote, which offers less immediate clarity on its financial value proposition.
Enterprise Readiness
Ligence HeartBoth tools are FDA cleared, HIPAA compliant, and offer BAAs, indicating readiness for healthcare environments. However, Ligence Heart offers more flexible deployment options (cloud-based, on-premise, hybrid) and explicitly mentions broad integration capabilities with PACS, EHR, and RIS, giving it a slight edge in adaptability for diverse enterprise infrastructures.
Innovation
Tempus ECG-AFTempus ECG-AF demonstrates a higher degree of innovation by offering a predictive capability for identifying future AF risk from standard ECGs, representing a significant advancement in proactive patient care and disease prevention. While Ligence Heart innovates by automating and enhancing a complex diagnostic workflow, Tempus ECG-AF's shift towards predictive analytics for a future event is a more novel application of AI in cardiology.
Support & Docs
Ligence HeartLigence Heart provides a dedicated support email and mentions the availability of user manuals and release notes on its website, indicating a more structured approach to customer support and resources. Tempus ECG-AF's publicly available information does not offer specific details about customer support channels, training, or comprehensive documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Ligence Heart | Tempus ECG-AF |
|---|---|---|
| Tool Name | Ligence Heart | Tempus ECG-AF |
| Primary Function/Purpose | Automates analysis and reporting of 2D transthoracic echocardiography to enhance diagnostic efficiency and accuracy. | Analyzes 12-lead ECG recordings to identify patients at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. |
| Input Data Type | 2D transthoracic echocardiography imaging data | 12-lead ECG recordings |
| Target Patient Population | Not specified | Patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
| Output/Analysis | Automated view classification, heart phase prediction, calculation of measurements (Area, Distance, Doppler, Volume, strain, Spectral and Tissue Doppler), report generation, and disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases). | Detection of signs associated with new onset Atrial Fibrillation (AF) within 12 months. |
Videos
Demos, reviews, and walkthroughs featuring Ligence Heart and Tempus ECG-AF.